Guselkumab in moderate to severe psoriasis in routine clinical care: an Italian 44-week real-life experience
Author:
Affiliation:
1. Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy
Publisher
Informa UK Limited
Subject
Dermatology
Link
https://www.tandfonline.com/doi/pdf/10.1080/09546634.2020.1800577
Reference19 articles.
1. Psoriasis Pathogenesis and Treatment
2. Psoriatic disease treatment nowadays: unmet needs among the “jungle of biologic drugs and small molecules”
3. IL-23 inhibitors for moderate-to-severe psoriasis
4. Shifting the focus - the primary role of IL-23 in psoriasis and other inflammatory disorders
5. Expression of Interleukin-12 is Increased in Psoriatic Skin
Cited by 43 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Effectiveness of guselkumab in patients with facial and/or genital psoriasis: Interim analysis results at Week 12 from the GULLIVER study;Journal of the European Academy of Dermatology and Venereology;2024-06-26
2. Effectiveness, safety and impact of guselkumab on sexuality and perceived stigmatization in patients with psoriasis in routine clinical practice: Week 28 results from the prospective German multicentre G‐EPOSS study;Journal of the European Academy of Dermatology and Venereology;2024-04-11
3. Real‐life data over 36 weeks of guselkumab treatment in psoriasis patients: A single‐center study from Turkey;Journal of Cosmetic Dermatology;2024-03-15
4. Effectiveness, safety and quality‐of‐life effects of guselkumab and ustekinumab in patients with psoriasis: Week 104 results from the non‐interventional, prospective, German multicentre PERSIST study;Journal of the European Academy of Dermatology and Venereology;2023-07-18
5. Safety of IL-23 p19 Inhibitors for the Treatment of Patients With Moderate-to-Severe Plaque Psoriasis: A Narrative Review;Advances in Therapy;2023-06-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3